Rights and permissions
About this article
Cite this article
Rofecoxib: greater risk of MI and sudden cardiac death than celecoxib. React. Wkly. 1020, 4 (2004). https://doi.org/10.2165/00128415-200410200-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200410200-00010